Utama › Kanser Prostat › Michigan › Ann Arbor
Kajian klinikal Kanser Prostat di Ann Arbor, MI
27 kajian untuk Kanser Prostat sedang mencari peserta di lokasi dalam dan sekitar Ann Arbor (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Mengambil pesertaFasa 3
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi jauh
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · 15 mi jauh
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · 18 mi jauh
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Mengambil pesertaFasa 3
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · 7 mi jauh
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi jauh
- dan 4 lagi
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Mengambil pesertaFasa 2
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi jauh
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · 15 mi jauh
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · 18 mi jauh
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Mengambil pesertaFasa 2
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · 7 mi jauh
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi jauh
- dan 4 lagi
Precision-Based Genomics in Prostate Cancer
Mengambil pesertaKajian pemerhatian
- University of Michigan, Ann Arbor
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
Mengambil pesertaFasa 1/2
- Research Site, Ann Arbor
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
Mengambil pesertaFasa 2
- VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Mengambil pesertaFasa 3
- University of Michigan ( Site 0005), Ann Arbor
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Mengambil pesertaFasa 3
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- University of Michigan Rogel Cancer Center, Ann Arbor
- Chelsea Hospital, Chelsea · 15 mi jauh
- dan 2 lagi
Prostate Active Surveillance Study
Mengambil pesertaKajian pemerhatian
- University of Michigan, Ann Arbor
COMPASS Study for Metastatic Castration-resistant Prostate Cancer
Mengambil pesertaKajian pemerhatian
- Rogel Cancer Center, Ann Arbor
EDRN Prostate MRI Biomarker Study
Mengambil pesertaKajian pemerhatian
- University of Michigan, Ann Arbor
Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer
Mengambil pesertaFasa 2
- University of Michigan Health, Ann Arbor
SPECT/CT Imaging for Dosimetry in 177Lu-PSMA-617 (Pluvicto) Therapy
Mengambil pesertaKajian pemerhatian
- University of Michigan Comprehensive Cancer Center, Ann Arbor
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Mengambil pesertaFasa 3
- Veteran's Administration Medical Center - Ann Arbor, Ann Arbor
- University of Michigan Rogel Cancer Center, Ann Arbor
- University of Michigan - Brighton Center for Specialty Care, Brighton · 18 mi jauh
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
Mengambil pesertaFasa 2
- VA Ann Arbor Healthcare System, Ann Arbor
Targeted Early Detection Program in Men at High Genetic Risk for Prostate Cancer
Mengambil pesertaKajian pemerhatian
- University of Michigan Rogel Cancer Center, Ann Arbor
Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer
Mengambil pesertaFasa 1/2
- University of Michigan Comprehensive Cancer Center, Ann Arbor
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
Mengambil pesertaFasa 2/3
- VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
Mengambil pesertaFasa 3
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · 7 mi jauh
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi jauh
- dan 4 lagi
A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer Patients
Mengambil peserta
- University of Michigan Comprehensive Cancer Center, Ann Arbor
Post-prostatectomy Radiation Therapy--Moderate Versus Ultra-hypofractionated (Also Known as Stereotactic Body Radiation Therapy [SBRT])
Mengambil pesertaFasa 2
- University of Michigan Rogel Cancer Center, Ann Arbor
Randomized Phase II Trial of Targeted Radiation With no Castration for Mcrpc
Mengambil pesertaFasa 2Sukarelawan sihat dialu-alukan
- VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
Interstitial Assessment of Architectural Heterogeneity in Prostate Cancer Using a Fine Needle Photoacoustic Probe
Mengambil pesertaKajian pemerhatian
- University of Michigan Rogel Cancer Center, Ann Arbor
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, Ann Arbor
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Mengambil pesertaFasa 3
- Saint Joseph Mercy Hospital, Ann Arbor
- University of Michigan Comprehensive Cancer Center, Ann Arbor
- Saint Joseph Mercy Chelsea, Chelsea · 15 mi jauh
- dan 1 lagi
Kajian Kanser Prostat di bandar lain
- New York City, NY103 kajian
- Houston, TX76 kajian
- Los Angeles, CA61 kajian
- Boston, MA59 kajian
- St. Louis, MO46 kajian
- Chicago, IL45 kajian
- San Francisco, CA45 kajian
- Philadelphia, PA44 kajian
- Baltimore, MD43 kajian
- Nashville, TN42 kajian
- Seattle, WA42 kajian
- Washington, DC38 kajian
Kajian lain di Ann Arbor
- Kanser Payudara26 kajian
- Kanser Paru-paru Bukan Sel Kecil26 kajian
- Kanser (semua jenis)25 kajian
- Kanser Kolorektal23 kajian
- Kanser Paru-paru23 kajian
- Kegagalan Jantung22 kajian
- Leukemia Mieloid Akut17 kajian
- Penyakit Kardiovaskular16 kajian
- Kanser Pankreas14 kajian
- Melanoma12 kajian
- Kanser Ginjal (Karsinoma Sel Renal)12 kajian
- Karsinoma Sel Skuamosa Kepala dan Leher12 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.